Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 276,000 | 1,000 | 233,000 | 42,000 | 431,000 |
| Other Working Capital | -840,000 | 937,000 | -469,000 | 473,000 | -671,000 |
| Other Operating Activity | 617,000 | 967,000 | 1,557,000 | 1,120,000 | 2,782,000 |
| Operating Cash Flow | $53,000 | $1,905,000 | $1,321,000 | $1,635,000 | $2,542,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -226,000 | -305,000 | -268,000 | -208,000 | -216,000 |
| Net Acquisitions | -52,000 | -6,000 | -2,987,000 | -73,000 | -70,000 |
| Purchase Sale Intangibles | -292,000 | -243,000 | -92,000 | -214,000 | -370,000 |
| Other Investing Activity | 166,000 | 84,000 | -634,000 | -46,000 | -2,928,000 |
| Investing Cash Flow | $-408,000 | $-540,000 | $-4,094,000 | $-545,000 | $-3,593,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 552,000 | 154,000 | -1,145,000 | -2,813,000 | -249,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 9,205,000 |
| Debt Repayment | -144,000 | -1,585,000 | -6,000 | N/A | N/A |
| Common Stock Issued | 6,000 | 0 | 8,000 | 5,000 | 12,000 |
| Dividend Paid | -555,000 | -654,000 | -705,000 | -1,156,000 | -952,000 |
| Other Financing Activity | -177,000 | 747,000 | 522,000 | -522,000 | -43,000 |
| Financing Cash Flow | $-318,000 | $-1,338,000 | $-1,326,000 | $-4,486,000 | $7,973,000 |
| Exchange Rate Effect | -31,000 | 46,000 | 23,000 | 71,000 | 12,000 |
| Beginning Cash Position | 3,425,000 | 3,352,000 | 7,426,000 | 10,751,000 | 3,817,000 |
| End Cash Position | 2,721,000 | 3,425,000 | 3,352,000 | 7,426,000 | 10,751,000 |
| Net Cash Flow | $-673,000 | $27,000 | $-4,099,000 | $-3,396,000 | $6,922,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 53,000 | 1,905,000 | 1,321,000 | 1,635,000 | 2,542,000 |
| Capital Expenditure | -529,000 | -751,000 | -480,000 | -426,000 | -601,000 |
| Free Cash Flow | -476,000 | 1,154,000 | 841,000 | 1,209,000 | 1,941,000 |